NOTE: This activity is available only as part of a paid subscription series; it is not available for purchase as a single, stand-alone activity.
The goal of this program is to improve diagnosis and management of Ménière disease (MD) and autoimmune ear disease (AIED), improve management of hearing loss and cognitive decline, and improve use of liquid biopsy for detection of HPV-mediated oropharyngeal carci-noma. After hearing and assimilating this program, the clinician will be better able to:
1. Review current clinical and diagnostic criteria for MD and AIED.
2. Prescribe appropriate medication for treatment of MD and AIED.
3. Evaluate evidence which supports a relationship between audi-tion and cognitive decline.
4. Implement appropriate interventions for suprathreshold hear-ing loss and cognitive decline.
5. Recognize the role of liquid biopsy in the surveillance of patients with high-risk HPV-mediated oropharyngeal carcinoma.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https:/www.audio-digest.org/Specialties/Otolaryngology
- Start Date: 2023-05-25 05:00:00
- End Date: 2023-05-25 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 2.0 hours
- MOC Credit Details: ABOHNS - 2.0 Point; Credit Type(s): Self-Assessment (ABOHNS)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Head & Neck, Otology